Rituximab for auto-immune alveolar proteinosis, a real life cohort study.

Berenice SoyezRaphael BorieCedric MenardJacques CadranelLeonidas ChavezVincent CottinEmmanuel GomezSylvain Marchand-AdamSylvie LeroyJean-Marc NaccacheHilario NunesMartine Reynaud-GaubertLaurent SavaleAbdellatif TaziLidwine Wemeau-StervinouMarie-Pierre DebrayBruno Crestani

Published in: Respiratory research (2018)

These data do not support rituximab as a second line therapy for patients with refractory aPAP.

Keyphrases

diffuse large b cell lymphoma
chronic lymphocytic leukemia
hodgkin lymphoma
electronic health record
big data
machine learning